A 3-year-old boy with severe obesity and pseudoacromegaly; short course treatment with Orlistat™

Iranian Journal of Diabetes and Lipid Disorders

Volumn 9, Issue , 2010, Pages

  Hasani Ranjbar, Shirin ^a   Shirzad, Nooshin ^a   Bakhshi, Farhad Mashayekh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Childhood obesity; Hereditary insulin resistance syndrome; Pseudoacromegaly

Indexed keywords

MULTIVITAMIN; TETRAHYDROLIPSTATIN;

ABSENCE OF SIDE EFFECTS; ACROMEGALY; ARTICLE; BODY MASS; CASE REPORT; CHILD; DISEASE COURSE; HUMAN; MALE; METABOLIC SYNDROME X; OBESITY; PRESCHOOL CHILD; SHORT COURSE THERAPY; WEIGHT GAIN;

EID: 78651261082     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cruz ML, Shaibi GQ, Weigensberg MJ, et al. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. Annu Rev Nutr 2005; 25:435-68.
2. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728.
3. Reinehr T, Hinney A, De Sousa G, et al. Definable somatic disorders in overweight children and adolescents. J Pediatr 2007; 150:618.
4. August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 2008; 93(12):4576-99.
5. LMS Parameters for Boys: Height for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.
6. LMS Parameters for Boys: BMI for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.
7. th ed, American Academy of Pediatrics, Elk Grove Village, IL 2004. p. 551
8. Hoppin, AG. Obesity. In: Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th ed, Walker, WA, Goulet, O, Kleinman, RE, et al (Eds), BC Decker, Ontario 2004. p.311
9. Leibel, RL, Chua, SC, Rosenbaum, M. Obesity. In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed, Scriver, CR, Beaudet, AL, Sly, WS, Valle, D (Eds), McGraw-Hill, New York 2001. p.3965.
10. Scott CR, Smith JM, Cradock MM, et al. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997; 100:84.
11. Hud JA, Cohen JB, Wagner JM, et al. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992; 128:941.
12. Richards GE, Cavallo A, Meyer WJ, et al. Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history. J Pediatr 1985; 107:893.
13. Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143(4): 500-5.
14. Svetlana Ten, Noel Maclaren. Insulin Resistance syndrome in children. J Clin Endocrinol Metab 2004; 89:2526-2539.
15. James F, Joel F. Habener. Defective Melanocortin 4 receptors in hyperphagia and morbid obesity. N Eng J Med 2003; 348: 1160-1163.
16. Rettenbacher E, Tarnow P, Brumm H, et al. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity. Exp Clin Endocrinol Diabetes 2007; 115(1):7-12.
17. Norgren S, Danielsson P, Jurold R, et al. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr 2003; 92(6):666-70.
18. Cruz ML, Shaibi GQ, Weigensberg MJ, et al. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. Annu Rev Nutr 2005; 25:435-68.
19. McGovern L, Johnson JN, Paulo R, et al. Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab 2008; 93(12):4600-5.